| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 691363-62-9 | Cyclo(L-alanyl-N-methyl-L-phenylalanyl-L-valyl-N-methyl-L-tyrosyl-2-aminobenzoyl)(9CI); Cycloaspeptide D |  | C35H41N5O6 | 詳情 | 供應商 | |
| 109171-15-5 | Cyclo(L-alanyl-L-phenylalanyl-L-leucyl-N-methyl-L-tyrosyl-2-aminobenzoyl); 1,4,7,10,13-Benzopentaazacyclohexadecine,cyclic peptide deriv.; Cycloaspeptide C |  | C35H41N5O6 | 詳情 | 供應商 | |
| 109171-14-4 | Cyclo(L-alanyl-N-methyl-L-phenylalanyl-L-leucyl-L-tyrosyl-2-aminobenzoyl)(9CI); 1,4,7,10,13-Benzopentaazacyclohexadecine,cyclic peptide deriv.; Cycloaspeptide B |  | C35H41N5O6 | 詳情 | 供應商 | |
| 17479-19-5 | Ergotaman-3',6',18-trione,9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'a,10a)-; Ergocristine,9,10-dihydro- (8CI); Ergocristine, dihydro- (7CI); 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, ergotaman-3',6',18-trione deriv.; Indolo[4,3-fg]quinoline, ergotaman-3',6',18-trione deriv.; 9,10-Dihydroergocristine; Dihydroergocristin; Dihydroergocristine; NSC 409663 |  | C35H41N5O5 | 詳情 | 供應商 | |
| 116740-51-3 | L-Phenylalanine,N-[1-[N2-[1-oxo-3-(10H-phenothiazin-10-yl)propyl]-L-arginyl]-L-prolyl]- (9CI); L 156903 |  | C35H41N7O5S | 詳情 | 供應商 | |
| 7240-12-2 | Lumiergocristine(6CI,8CI) |  | C35H41N5O6 | 詳情 | 供應商 | |
| 143760-27-4 | 1-Piperazineethanol,4-[4,4-bis(4-fluorophenyl)butyl]-a-[(diphenylamino)methyl]-, hydrochloride (1:2); 1-Piperazineethanol,4-[4,4-bis(4-fluorophenyl)butyl]-a-[(diphenylamino)methyl]-, dihydrochloride (9CI) |  | C35H41Cl2F2N3O | 詳情 | 供應商 |